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A V-shaped ligand Bis(2-benzimidazolymethyl)amine (bba) and its nickel(II) picrate (pic) complex, with composition
[Ni(bba)2](pic)2·3MeOH, have been synthesized and characterized on the basis of elemental analyses, molar conductivities, IR
spectra,andUV/vismeasurements.Inthecomplex,theNi(II)ionissix-coordinatedwithaN2O4 ligandset,resultinginadistorted
octahedron coordination geometry. In addition, the DNA-binding properties of the Ni(II) complex have been investigated by
electronic absorption, ﬂuorescence, and viscosity measurements. The experimental results suggest that the nickel(II) complex
binds to DNA by partial intercalation binding mode.
1.Introduction
Binding studies of small molecules to DNA are very impor-
tant in the development of DNA molecular probes and new
therapeutic reagents [1]. Transition metal complexes have
attractedconsiderableattentionascatalyticsystemsforusein
the oxidation of organic compounds [2], probes in electron-
transfer reactions involving metalloproteins [3], and interca-
lators with DNA [4]. Numerous biological experiments have
demonstrated that DNA is the primary intracellular target of
anticancer drugs; interaction between small molecules and
DNA can cause damage in cancer cells, blocking the division
and resulting in cell death [5–7].
Since the benzimidazole unit is the key-building block
for a variety of compounds which have crucial roles in
the functions of biologically important molecules, there is
a constant and growing interest over the past few years
for the synthesis and biological studies of benzimidazole
derivatives [8–10]. Since the characterization of urease as a
nickel enzyme in 1975, the knowledge of the role of nickel
in bioinorganic chemistry has been rapidly expanding [11].
The interaction of Ni(II) complexes with DNA appears to be
mainly dependent on the structure of the ligand exhibiting
intercalative behavior [12–14].
In this context, we synthesized and characterized a novel
Ni(II) complex. Moreover, we describe the interaction of the
novel Ni(II) complex with DNA using electronic absorption
and ﬂuorescence spectroscopy and viscosity measurements.
2. Experimental
2.1. Materials and Methods. Calf thymus DNA (CT-DNA)
and Ethidium bromide (EB) were purchased from Sigma
Chemicals Co. (USA). All chemicals used were of analytical
grade. All the experiments involving interaction of the ligand
and the complexes with CT-DNA were carried out in doubly
distilled water buﬀer containing 5mM Tris and 50mM NaCl
and adjusted to pH 7.2 with hydrochloric acid. A solution
of CT-DNA gave a ratio of UV absorbance at 260 and
280nm of about 1.8–1.9, indicating that the CT-DNA was
suﬃciently free of protein [15]. The CT-DNA concentration
per nucleotide was determined spectrophotometrically by
employing an extinction coeﬃcient of 6600M−1 cm−1 at
260nm [16].
Elemental analyses were performed on Carlo Erba
1106 elemental analyzer. The IR spectra were recorded
in the 4000–400cm−1 region with a Nicolet FT-VERTEX2 Bioinorganic Chemistry and Applications
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Scheme 1: The synthesis of ligand bba and its Ni(II) complex.
70 spectrometer using KBr pellets. Electronic spectra were
taken on a Lab-Tech UV Bluestar spectrophotometer. The
ﬂuorescence spectra were recorded on a 970-CRT spec-
troﬂuorophotometer. 1HNMR spectra were obtained with
a Mercury plus 400MHz NMR spectrometer with TMS
as internal standard and DMSO-d6 as solvent. Electrolytic
conductancemeasurementsweremadewithaDDS-11Atype
conductivitybridgeusinga10−3 mol·L−1 solutioninDMFat
room temperature.
2.2. Electronic Absorption Spectra. Absorption titration
experiment was performed with ﬁxed concentrations of the
complexes while gradually increasing concentration of CT-
DNA. While measuring the absorption spectra, a proper
amount of CT-DNA was added to both compound solution
andthereferencesolutiontoeliminatetheabsorbanceofCT-
DNA itself. From the absorption titration data, the binding
constant (Kb) was determined using [17]
[DNA]
εa −εf
=
[DNA]
εb −εf
+
1
Kb

εb −εf
,( 1 )
where [DNA] is the concentration of DNA in base pairs, the
apparent absorption coeﬃcient, εa, εf,a n dεb correspond to
Aobsd/[M], the extinction coeﬃcient of the free compounds
and the extinction coeﬃcient of the compound when fully
b o u n dt oD N A ,r e s p e c t i v e l y .I np l o t so f[ D N A ] / ( εa − εf)
versus [DNA], Kb is given by the ratio of slope to the
intercept.
2.3. Fluorescence Spectra. EB emits intense ﬂuoresence in
the presence of CT-DNA due to its strong intercalation
between the adjacent CT-DNA base pairs. It was previously
reported that the enhanced ﬂuorescence can be quenched
by the addition of a second molecule [18]. The extent
of ﬂuorescence quenching of EB bound to CT-DNA can
be used to determine the extent of binding between the
second molecule and CT-DNA. The competitive binding
experiments were carried out in the buﬀer by keeping
[DNA]/[EB] = 1 and varying the concentrations of the
compounds. The ﬂuorescence spectra of EB were measured
using an excitation wavelength of 520nm and the emission
range was set between 550 and 750nm. The spectra were
analyzed according to the classical Stern-Volmer equation
[19],
I0
I
= 1+Ksv[Q],( 2 )
where I0 and I are the ﬂuorescence intensities at 599nm in
the absence and presence of the quencher, respectively, Ksv
is the linear Stern-Volmer quenching constant, [Q] is the
concentration of the quencher.
2.4. Viscosity Measurements. Viscosity experiments were
conducted on an Ubbelohde viscometer, immersed in a
thermostated water-bath maintained at 25.0 ± 0.1◦C. DNA
samples approximately 200bp in average length were pre-
paredbysonicatinginordertominimizecomplexitiesarising
from DNA ﬂexibility [20]. Titrations were performed for the
compounds (3mM), and each compound was introduced
intotheCT-DNAsolution(50μM)presentintheviscometer.
Data were presented as (η −η0)
1/3 versus the ratio of the
concentration of the compound to CT-DNA, where η is
the viscosity of CT-DNA in the presence of the complex,
and η0 is the viscosity of CT-DNA alone. Viscosity values
were calculated from the observed ﬂow time of CT-DNA
containing solutions corrected from the ﬂow time of buﬀer
alone (t0), η = (t −t0)/t0.Bioinorganic Chemistry and Applications 3
2.5. Synthesis. The synthetic route for the ligand bba and its
Ni(II) complex are shown in Scheme 1.
2.5.1. Bis(2-benzimidazolymethyl)amine (bba). The ligand
bba was synthesized according to the procedure reported
by Berends and Stephan [21]. The infrared spectra and UV
spectra of the bba were almost consistent with the literature.
Elemental analysis: C16H15N5 (Mr = 277.33g·mol−1)c a l c d :
C 69.30; H 5.45; N 25.26%; found: C 69.35; H 5.47; N
25.16%. IR (KBr, pellet, cm−1): 1270s (νC–N), 1620s (νC=N),
UV-vis (λ, nm): 277, 283, ε277 = 5.99 × 102 L·mol−1·cm−1,
ε283 = 5.73 × 102 L·mol−1·cm−1. 1HNMR (DMSO-d6,
300MHz) δ:1 2 . 3( 1 H ,N - H ) ;7 . 1 4 4( m ,4 H ) ;7 . 5( d ,4 H ) ;4 . 0
(s, 4H). ΛM (DMF, 297K): 1.29S·cm2·mol−1.
2.5.2. [Ni(bba)2](pic)2·3MeOH. The ligand bba (0.4mmol)
and Ni(II) picrate (0.2mmol) were dissolved in methanol
(15mL). A blue-green crystalline product which formed
rapidly was ﬁltered oﬀ, washed with methanol and abso-
lute Et2O, and dried in vacuo. The dried precipitate was
dissolved in DMF resulting in a blue-green solution that
was allowed to evaporate at room temperature. Blue-green
crystals suitable for X-ray diﬀraction studies were obtained
after one week. C47H36N16Ni O17 (Mr = 1155.63g·mol−1)
calcd: C 48.85; H 3.14; N 19.39%; found: C 48.79; H
3.16; N 19.53%. IR (KBr, pellet, cm−1): 1272s (νC–N),
1434 (νC=N–C=C), 1487s (νC=N), UV-vis (λ, nm): 275,
280, 407, ε275 = 6.55 × 102 L·mol−1·cm−1, ε280 = 6.50 ×
102 L·mol−1·cm−1, ε407 = 7.99 × 102 L·mol−1·cm−1. ΛM
(DMF, 297K): 128.5S·cm2·mol−1.
2.6.CrystalStructureDetermination. Asuitablesinglecrystal
was mounted on a glass ﬁber and the intensity data were
collected on a Bruker Smart CCD diﬀractometer with
graphite-monochromated Mo Kα radiation (λ = 0.71073 ˚ A)
at 296K. Data reduction and cell reﬁnement were performed
using the SMART and SAINT programs [22]. The structure
was solved by direct methods and reﬁned by full-matrix least
squares against F2 of data using SHELXTL software [23]. All
Ha t o m sw e r ef o u n di nd i ﬀerent electron maps and were
subsequently reﬁned in a riding-model approximation with
C–Hdistancesrangingfrom0.95to0.99 ˚ A.Basiccrystaldata,
description of the diﬀraction experiment, and details of the
structure reﬁnement are given in Table 1.
3. Results andDiscussion
The ligand bba and its Ni(II) complex are very stable
in the air. They are remarkably soluble in polar sol-
vents such as DMF, DMSO, and MeCN; slightly soluble
in ethanol, methanol, ethyl acetate, and chloroform. The
molar conductivities in DMF solution indicate that bba
(1.29S·cm2·mol−1) is nonelectrolyte compound and its
Ni(II) complex is 1:2 electrolyte compound [24].
3.1. Spectral Characterization. In the bba ligand, a strong
band is found at ca. 1270cm−1 together along with a broad
band at 1436cm−1. By analogy with the assigned bands of
Table 1: Crystallographic data and data collection parameters for
the Ni(II) complex.
Complex [Ni(bba)2](pic)2·3MeOH
Molecular formula C47H36N16NiO17
Molecular weight 1155.63
Crystal system Triclinic
Space group P-1
a(˚ A) 10.4758 (9)
b(˚ A) 16.1097 (13)
c(˚ A) 17.2302 (14)
α (◦) 107.5590 (10)
β (◦) 107.5880 (10)
γ (◦) 96.9150 (10)
V (˚ A3) 2570.1 (4)
Z 2
ρcald (mg m−3) 1.493
Absorption coeﬃcient (mm−1) 0.467
F (000) 1188
Crystal size (mm) 0.41 × 0.38 × 0.31
θ range for data collection (◦) 2.04–25.00
h/k/l (max, min) −12, 12/−16, 19/−20, 20
Reﬂections collected 18579
Independent reﬂections 8974 [R(int) = 0.0203]
Data/restraints/parameters 8974/6/746
Goodness-of-ﬁt on F2 1.097
Final R1, wR2 indices [I>2σ(I)] 0.0383, 0.1135
R1, wR2 indices (all data) 0.0466, 0.1194
Largest diﬀerences peak and hole (e˚ A−3) 0.734 and −0.384
imidazole, the former can be attributed to ν(C=N–C=C),
while the latter can be attributed to ν(C=N) [25–27]. One
of them shift to the higher frequency by around 41cm−1 in
the complex, which implies direct coordination of all three
imine nitrogen atoms to metal ions. This is the preferred
nitrogen atom for coordination as found for other metal
complexes with benzimidazoles [28]. Information regarding
thepossiblebondingmodesofthepicrateandbenzimidazole
rings may also be obtained from the IR spectra, such as 709,
744, 1272, 1363, 1434, 1487, and 1633cm−1 [29]. This fact
agrees with the result determined by X-ray diﬀraction.
DMF solutions of ligand bba and its complexes show, as
expected, almost identical UV spectra. The UV bands of bba
(275, 280nm) are only marginally blue shifted (1-2nm) in
the complexes, which is clear evidence of C=N coordination
to the metal ions center. The absorption bands are assigned
to π → π∗ (imidazole) transitions. The bands of picrate
(407nm) are assigned to π → π∗ transitions.
3.2. Crystal Structure of [Ni(bba)2](pic)2·3MeOH. The
molecular structure of the Ni(II) complex is shown in
Figure 1,s e l e c t e db o n dl e n g t h sa n da n g l e sa r es u m m a r i z e d
in Table 2. The Ni(II) atom is six-coordinate with a NiN4O2
environment. The bba ligand acts as a tridentate N-donor
and O-donor. The coordination geometry of the Ni(II)4 Bioinorganic Chemistry and Applications
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Figure 1: The molecular structure of the Ni(II) complex showing displacement ellipsoids at the 30% probability level. Hydrogen atoms have
been omitted for clarity.
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Figure 2: Electronic spectra of the Ni(II) complex (30μM) in the presence of 0, 5, 10, 20, 30, 40, 50, 60, 70, 80, and 90μL CT-DNA. [DNA]
= 2.5 × 10
−5 M. Arrow shows the absorbance changes upon increasing CT-DNA concentration. Plots of [DNA]/(εa − εf)v e r s u s[ D N A ]f o r
the titration of the Ni(II) complex with CT-DNA.
Table 2: Selected bond lengths (˚ A) and angles (deg) of the Ni(II) complex.
Bond lengths
Ni–N(1) 2.1647 (19) Ni–N(4) 2.0793(18) Ni–N(6) 2.1788(19)
Ni–N(3) 2.0899 (19) Ni–N(7) 2.0667 (18) Ni–N(9) 2.0628 (19)
Bond angles
N(1)–Ni–N(6) 94.12 (7) N(9)–Ni–N(7) 173.40 (7) N(9)–Ni–N(4) 98.11 (7)
N(3)–Ni–N(7) 173.40 (7) N(3)–Ni–N(1) 79.29 (7) N(7)–Ni–N(4) 166.55 (7)
N(9)–Ni–N(3) 107.52 (7) N(7)–Ni–N(3) 98.95 (7) N(3)–Ni–N(4) 89.98 (7)
N(1)–Ni–N(9) 173.19 (7) N(7)–Ni–N(1) 90.23 (7) N(1)–Ni–N(4) 81.52 (7)
N(9)–Ni–N(6) 79.07 (8) N(7)–Ni–N(6) 81.11 (7) N(4)–Ni–N(6) 88.87 (7)Bioinorganic Chemistry and Applications 5
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Figure 3: Emission spectra of EB bound to DNA in the presence of the complex. [Complex] = 3 × 10
−3 M; λex = 520nm. The arrow shows
the intensity changes upon increasing concentrations of the complex. Fluorescence quenching curves of EB bound to CT-DNA by the Ni(II)
complex. (Plots of I0/I versus [Complex]/DNA.).
may be best described as distorted octahedral with four
coordination nitrogen atoms from an ideal equatorial plane.
The maximum deviation (N9) from the plane containing
these four N atoms is 0.764 ˚ A. The bond average length
between the Ni ion and the apical N atom (N1, N6) is
2.171 ˚ A, which is about 0.097 ˚ A longer than the bond average
length between the Ni ion and four coordination N atoms
from an equatorial plane. This geometry is assumed by the
Ni(II) to relieve the steric crowding. Therefore, compared
with a regular octahedron, it reﬂects a relatively distorted
coordination octahedron around Ni(II).
3.3. Spectral Studies of the Interactions with DNA
3.3.1. Electronic Absorption Titration. Electronic absorption
spectroscopy is universally employed to determine the bind-
ing characteristics of metal complexes with DNA [30–32].
The absorption spectra of the Ni(II) complex in the absence
andpresenceofCT-DNAaregiveninFigure 2.The r ear etw o
well-resolved bands at about 272, 278nm for the complex.
The λ for the ligand increases only from 272 to 273, and for
thecomplexfrom278to279nm,aslightredshiftabout1nm
under identical experimental conditions. The slight red shift
suggests that the Ni(II) complex interacts with DNA [33].
The binding constant Kb for the complex has been
determined from the plot of [DNA]/(εa − εf) versus [DNA]
andwasfoundtobe1.12×103 M −1.Comparedwiththoseof
the so-called DNA-intercalative ruthenium complexes (1.1×
104–4.8 × 104 M−1)[ 34], the binding constants (Kb)o ft h e
Ni(II) complex suggest that the complex with DNA with an
aﬃnity is less than the classical intercalators.
3.3.2. Fluorescence Spectroscopic Studies. intensity in the EB-
DNA adduct allows determination of the aﬃnity of the
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Figure 4: Eﬀect of increasing amounts of the Ni(II) complex on the
relative viscosity of CT-DNA at 25.0 ± 0.1◦C.
complex for DNA, whatever the binding mode may be.
If a complex can replace EB from DNA-bound EB, the
ﬂuorescence of the solution will be quenched due to the
fact that free EB molecules are readily quenched by the
surrounding water molecules [35]. For all the compounds,
no emission was observed either alone or in the presence
of CT-DNA in the buﬀer. The ﬂuorescence quenching of
EB bound to CT-DNA by the Ni(II) complex is shown in
Figure 3. The quenching of EB bound to CT-DNA by the
Ni(II) complex is in good agreement with the linear Stern-
Volmer equation, which provides further evidence that the
Ni(II) complex bind to DNA. The quenching plots illustrate
that the quenching of EB bound to DNA by the complex is
in good agreement with the linear Stern-Volmer equation,
which also proves that the complex binds to DNA. The Ksv6 Bioinorganic Chemistry and Applications
value for the Ni(II) complex is 3.12 × 104 M−1. The data
suggest that the Ni(II) complex interacts with DNA.
3.3.3. Viscosity Studies. Optical photophysical techniques are
widely used to study the binding model of the ligand,
metal complexes, and DNA but not to give suﬃcient clues
to support a binding model. Therefore, viscosity measure-
ments were carried out to further clarify the interaction of
metal complexes and DNA. Hydrodynamic measurements
that are sensitive to the length change (i.e., viscosity and
sedimentation) are regarded as the least ambiguous and
the most critical tests of a binding model in solution in
the absence of crystallographic structural data [15, 20]. A
classical intercalative mode causes a signiﬁcant increase in
viscosity of DNA solution due to increase in separation
of base pairs at intercalation sites and hence an increase
in overall DNA length. By contrast, complexes that bind
exclusively in the DNA grooves bypartial and/or nonclassical
intercalation, under the same conditions, typically cause
less pronounced (positive or negative) or no change in
DNA solution viscosity [20] .T h ev a l u e so f( η − η0)1/3
were plotted against [compound]/[DNA] (Figure 4). For the
Ni(II) complex, as increasing the amounts of compound, the
viscosity of DNA decreases steadily. The decreased relative
viscosity of DNA may be explained by a binding mode which
produced bends or kinks in the DNA and thus reduced its
eﬀective length and concomitantly its viscosity. The results
suggest that the Ni(II) complex may bind to DNA by partial
intercalation.
4. Conclusions
In this paper, a new Ni(II) complex has been synthesized and
characterized. Moreover, the DNA-binding properties of the
Ni(II) complex were investigated by electronic absorption,
ﬂuorescence, and viscosity measurements. The experimental
results indicate that the Ni(II) complex can bind to CT-
DNA by partial intercalation mode. Information obtained
from our study will be helpful to understand the mechanism
of interactions of benzimidazoles and their complexes with
nucleic acids and should be useful in the development of
potential probes of DNA structure and conformation.
Appendix
AdditionalData
CCDC 825141 contains the additional crystallographic data
for this paper. These data can be obtained free of charge
from The Cambridge Crystallographic Data Centre via
http://www.ccdc.cam.ac.uk/data request/cif.
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